Alrise Develops Controlled Release Depot Formulations For Proteinpeptide And Small Molecule Drugsthe Cornerstone Of Alrise S Business Is Its Patented Parenteral Drug Delivery Technology Imsusafor The Encapsulation Of Active Pharmaceutical Ingredients In Biodegradable Polymeric Nanoor Microparticles Alrise Offers Its Technology And Experience To Pharma Biotechand Generic Drug Companies With The Objective Of Developing New Products Or Improving Current Products Based On Controlled Release Formulations Business Areasthe Development Of Innovative Solutions For Target Product Profiles Given By Its Partners Is Alrise S Core Competenceservices Mainly Apply To Areas Offormulation Of New Chemical Entitiesin Co Operation With Drug Developing Companies Reformulation Of Pharmaceutical Products In The Context Of Product Lifecycle Managementin Co Operation With Originators Reformulation Of Off Patent Drugs To Develop Supergeneric Productsin Co Operation With Generics Companies
